Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fortress Biotech Inc 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLAND FL 10014 USA

www.fortressbiotech.com P: 781-652-4500

Description:

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

Key Statistics

Overview:

Market Capitalization, $K 19,406
Enterprise Value, $K -62,774
Shares Outstanding, K 8,943
Annual Sales, $ 75,740 K
Annual Net Income, $ -86,580 K
Last Quarter Sales, $ 34,750 K
Last Quarter Net Income, $ -5,050 K
EBIT, $ -177,370 K
EBITDA, $ -165,950 K
60-Month Beta 1.52
% of Insider Shareholders 26.90%
% of Institutional Shareholders 96.51%
Float, K 6,537
% Float 73.10%
Short Volume Ratio 0.62

Growth:

1-Year Return -80.71%
3-Year Return -96.24%
5-Year Return -92.43%
5-Year Revenue Growth -59.62%
5-Year Earnings Growth 39.77%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.94 on 11/14/23
Latest Earnings Date 04/04/24
Earnings Per Share ttm -12.19
EPS Growth vs. Prev Qtr 73.88%
EPS Growth vs. Prev Year 74.92%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 10/10/23

FBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -770.86%
Return-on-Assets % -35.23%
Profit Margin % -114.31%
Debt/Equity -3.46
Price/Sales 0.18
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.49
Interest Coverage -14.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar